BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 8088295)

  • 1. Clinical perspectives in congenital adrenal hyperplasia due to 11β-hydroxylase deficiency.
    Bulsari K; Falhammar H
    Endocrine; 2017 Jan; 55(1):19-36. PubMed ID: 27928728
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Congenital adrenal hyperplasia].
    Stanić M; Nesović M
    Med Pregl; 1999; 52(11-12):447-54. PubMed ID: 10748766
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Virilizing adrenal tumour mimicking congenital adrenal hyperplasia with P450c11 (11 beta-hydroxylase) deficiency.
    Werder EA; Voutilainen R; Zachmann M
    Eur J Pediatr; 1994 Jun; 153(6):411-5. PubMed ID: 8088295
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Image diagnosis of adrenal disorders. III. "Nonfunctioning" adrenal adenoma, weak mineralocorticoids producing adrenal carcinoma, congenital adrenogenital syndrome due to 21-hydroxylase deficiency--simple virilizing form, and pheochromocytoma].
    Yamakita N; Kikuchi M; Minamori Y; Goshima E; Murase H; Murayama M; Yasuda K; Miura K; Imaeda T; Sugiyama K
    Nihon Naibunpi Gakkai Zasshi; 1985 Jun; 61(6):677-89. PubMed ID: 2996954
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Congenital adrenal hyperplasia: 11beta-hydroxylase deficiency.
    Peter M
    Semin Reprod Med; 2002 Aug; 20(3):249-54. PubMed ID: 12428205
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Virilizing adrenal adenoma and primary amenorrhea in a girl with adrenal hyperplasia.
    Forsbach G; Güitrón-Cantú A; Vázquez-Lara J; Mota-Morales M; Díaz-Mendoza ML
    Arch Gynecol Obstet; 2000 Feb; 263(3):134-6. PubMed ID: 10763843
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adrenal scan in 17-alpha-hydroxylase deficiency: false indication of adrenal adenoma.
    Shore RM; Lieberman LM; Newman TJ; Friedman A; Bargman GJ
    Clin Nucl Med; 1981 Jul; 6(7):310-2. PubMed ID: 7016381
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adrenocortical cancer: steroid biosynthesis and metabolism evaluated by urinary metabolites.
    LIPSETT MB; WILSON H
    J Clin Endocrinol Metab; 1962 Sep; 22():906-15. PubMed ID: 14465754
    [No Abstract]   [Full Text] [Related]  

  • 9. ADRENOCORTICAL CARCINOMA WITH FEMINIZATION AND HYPERTENSION ASSOCIATED WITH A DEFECT IN 11-BETA-HYDROXYLATION.
    WEST CD; KUMAGAI LF; SIMONS EL; DOMINGUEZ OB; BERLINER DL
    J Clin Endocrinol Metab; 1964 Jul; 24():567-79. PubMed ID: 14212075
    [No Abstract]   [Full Text] [Related]  

  • 10. In vitro studies of enzymatic activities in human adrenal tumors.
    Degenhart HJ; Drop SL; Hoogerbrugge J; van Seters AP; de Vries HR
    Horm Res; 1982; 16(2):96-9. PubMed ID: 6980816
    [No Abstract]   [Full Text] [Related]  

  • 11. Adrenocortical tumor in a patient with congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
    Pang S; Becker D; Cotelingam J; Foley TP; Drash AL
    Pediatrics; 1981 Aug; 68(2):242-6. PubMed ID: 6267548
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Steroid biochemistry of virilising adrenal tumours in childhood.
    Honour JW; Price DA; Taylor NF; Marsden HB; Grant DB
    Eur J Pediatr; 1984 Aug; 142(3):165-9. PubMed ID: 6088244
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A virilizing adrenal tumor with borderline elevation of urinary 17-ketosteroids.
    David R; August G; Gandy HM
    Pediatrics; 1968 Jul; 42(1):139-48. PubMed ID: 4297953
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.